Searched for
EMCURE PHARMA US FDA INSPECTION
Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...- Delhi CM Rekha Gupta directs district administration to inspect Shalimar Bagh's Fortis HospitalFortis Hospital inspection: Delhi Chief Minister Rekha Gupta has ordered an immediate inspection of Shalimar Bagh's Fortis Hospital followi...
- Oil slide powers India's stock benchmarks to longest weekly winning run 7 monthsIndian stock markets achieved their longest winning streak in seven months, with the Nifty 50 and BSE Sensex closing higher. Falling crude ...
- Maharashtra FDA bans serving food in newspapers, issues statewide food safety orderMaharashtra FDA has launched 'Safe Food, Healthy Maharashtra' banning food served on newspapers and enforcing strict hygiene. Hotels, resta...
- UN watchdog says Iran nuclear inspections 'going to happen'UN nuclear watchdog chief Rafael Grossi confirmed inspections at Iranian atomic sites are imminent, following a preliminary deal between Te...
- UN watchdog says Iran nuclear inspections 'going to happen'UN nuclear watchdog chief Rafael Grossi confirmed inspections at Iranian atomic sites are imminent, following a preliminary deal between Te...
- Trump says he would 'cancel meetings' with Iran if they deny IAEA nuclear inspectionsPresident Trump declared he would halt technical talks with Iran if nuclear inspections by the IAEA are denied, asserting Washington has se...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- Trump says IAEA will inspect Iran's nuclear sites at the 'appropriate time'US President Donald Trump has contradicted Iran's claims regarding inspections of its nuclear sites. He stated that International Atomic En...
- Iran makes 'major concessions', agrees to long-term nuclear inspections, claims TrumpUS President Donald Trump announced that Iran has agreed to the highest level of nuclear inspections indefinitely, ensuring "nuclear honest...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
- Plan in the works to let hospitals import med equipment directlyIndia's drug regulator is proposing to allow hospitals to directly import advanced medical equipment like MRI and CT scanners, bypassing cu...
- USFDA concludes inspection at Jubilant HollisterStier's Spokane plant with 8 observationsJubilant Pharmova announced its US subsidiary, Jubilant HollisterStier LLC, underwent a USFDA inspection. The facility in Spokane, Washingt...
- FDA expands recall to all Clover Hill Dairy cheeses after listeria found in products and facilityUS food safety authorities have expanded a cheese recall due to Listeria contamination, now encompassing all products from Clover Hill Dair...
- Maharashtra FDA bars hospitals from forcing patients to buy medicines in-houseMaharashtra's Food and Drug Administration has issued a significant directive. Hospitals and medical practitioners must now allow patients ...
- Dabur India shares in focus after US FDA places drugs from Silvassa plant under import alert. Here’s whyDabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data ...
- US drug regulator issues import alert for drugs made at a Dabur India plantThe US Food and Drug Administration has placed Dabur India's factory on an import alert. This action follows an inspection that revealed si...
- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
Load More
